Lam Research Corporation (NASDAQ:LRCX) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Lam Research Corporation (NASDAQ:LRCXGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirty-one analysts that are currently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $125.08.

Several equities research analysts have recently weighed in on the company. B. Riley increased their price objective on Lam Research from $130.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. TD Cowen boosted their price objective on shares of Lam Research from $125.00 to $145.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Cantor Fitzgerald raised their target price on shares of Lam Research from $155.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft upgraded shares of Lam Research from a “hold” rating to a “buy” rating and boosted their price target for the stock from $100.00 to $150.00 in a research note on Monday, September 29th. Finally, Wells Fargo & Company increased their price objective on Lam Research from $98.00 to $135.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd.

Get Our Latest Stock Analysis on LRCX

Lam Research Price Performance

LRCX stock opened at $141.51 on Friday. The company has a market capitalization of $178.45 billion, a P/E ratio of 34.02, a PEG ratio of 1.73 and a beta of 1.84. Lam Research has a twelve month low of $56.32 and a twelve month high of $153.70. The business has a 50 day simple moving average of $119.06 and a 200-day simple moving average of $96.78. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. The business had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company’s revenue was up 33.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, equities analysts anticipate that Lam Research will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were given a $0.26 dividend. This is an increase from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 24th. Lam Research’s dividend payout ratio (DPR) is 25.00%.

Insider Buying and Selling at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.31% of the stock is currently owned by corporate insiders.

Institutional Trading of Lam Research

Large investors have recently made changes to their positions in the stock. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research during the second quarter valued at $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the second quarter valued at $27,000. Sound Income Strategies LLC acquired a new stake in shares of Lam Research during the third quarter valued at $41,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research during the second quarter valued at $29,000. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of Lam Research during the second quarter valued at $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.